Follistatin 344


Myostatin antagonist / follistatin isoform

An isoform of the endogenous myostatin antagonist follistatin, sold as a research peptide for muscle hypertrophy applications.

Abstract

Follistatin 344 is an isoform of the endogenous protein follistatin (the 344-residue form, encoded as one splice variant of the FST gene). Follistatin binds and antagonizes myostatin (GDF-8), a TGF-beta family member that negatively regulates skeletal muscle mass. Antagonizing myostatin produces increased muscle hypertrophy and reduced muscle atrophy in animal models. Follistatin 344 is sold as a research peptide for muscle development applications. The compound is administered subcutaneously or intramuscularly; oral bioavailability is poor. There is no human clinical trial record for follistatin 344 specifically; the related ACE-031 (a soluble activin receptor type IIB Fc fusion) was developed pharmaceutically and reached Phase 2. Investigational doses range widely with poorly characterized safety; chronic myostatin antagonism may have cardiac and tendon implications that are not adequately studied.

FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human or animal consumption. All information is provided for research and educational purposes only.


Browse all monographs

Previous monograph
Next monograph